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Research Article
Capillary electrophoresis immunoassay
using magnetic beads
Protein A-coated magnetic beads (0.3 mm) have been trapped in a small portion of a neu-
trally coated capillary (50 mm id). Anti-b-lactoglobulin (b-LG) antibodies have then been
immobilized on the beads through strong affinity with protein A to subsequently capture
b-LG from model or real samples. Once the immunocomplexes formed at physiological
pH, a discontinuous buffer system has been used to release the partners and pre-
concentrate them by transient ITP. The antigens and antibodies have finally been separated
by CZE and detected by UV absorbance. An LOQ of 55 nM has been achieved. This meth-
odology has been applied to quantify native b-LG in pasteurized and ultra-high-tempera-
ture-treated bovine milk. All the described procedures, including immunosorbent prepara-
tion, sample extraction, cleanup, preconcentration, and separation are completely auto-
mated on a commercial CE instrument. As this CE immunoassay method is simple, rapid,
selective, and sensitive, it should be a practical and attractive technology for the analysis of
complicated biological samples.
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1 Introduction
Since CE combines high separation efficiency, low sample
consumption, speed, and compatibility with a wide range of
detectors, this technique has played a major role in many
forefront fields such as genome sequencing, proteomic, and
metabolic research.
In the context of complex biological sample analysis,
sample preparation that may include desalting, immunode-
pletion of major components or concentration of a subclass
of compounds are often mandatory to further analyze the
compounds of interest. In the field of electrokinetically dri-
ven separation, online immunoaffinity CE (IA-CE) has
opened the way to more straightforward protocols [1–5]. It
involves the online hybridization of two technologies:
immunoaffinity extraction and CE. The method permits the
online capture of target molecules on a solid support that
may contain immobilized antigens, antibodies, or receptors.
Then, the captured analyte molecules are released from the
solid support by changing the composition of the running
buffer and separated by CE. This online combination limits
the pretreatment of complicated samples because selective
sample extraction, cleanup, and even enrichment can be
achieved simultaneously prior to CE. So far, different
approaches have been developed to prepare the immunosor-
bent phase. Open tubular [6–11], packed [12–16], and mono-
lithic [17–19] capillaries are mostly used to immobilize the
antibodies. For instance, Phillips’ group described an
immunoaffinity CE technique with Fab fragment covalently
immobilized on the walls of a fused-silica capillary [9]. After
functionalization of one-third of the capillary, four kinds of
neuropeptides and their tracers were captured, released,
separated by CE, and finally detected by LIF. As an alter-
native to open tubular columns, a short packed bed of con-
trolled-porous glass beads, containing covalently immobi-
lized Fab fragment was integrated within a capillary by Guz-
man [13]. Gonadotropin-releasing hormone in serum and
urine was extracted and detected with this technique. The
monolithic column format that is currently under constant
progress also showed its potential application as a support
material for IA-CE. For example, a Protein G containing
monolithic preconcentrator has been used in a CE system for
the extraction and preconcentration of IgG from human
serum [19].
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All these approaches have contributed to the develop-
ment of CE, making it an easy and versatile technique for
complex systems, but still with some limitations. In open
tubular configuration, the amount of antibodies immobi-
lized on the capillary surface is restricted. This induces a low
capacity and limits the efficiency of immunoextraction. The
use of packed beds offers a better loading capacity, however
the column preparation is laborious and requires the use of
frits to maintain the beads in the capillary. As monolithic
columns are synthesized in situ, it represents a very interest-
ing alternative when narrow capillaries or microchannels
have to be functionalized. Nevertheless, the synthesis proce-
dure is time-consuming and has to be well established to
provide reproducible results [20]. As briefly described, the
different methodologies derived from LC to perform IA-CE
represent very interesting options but alternative approaches
must be developed to overcome the existing drawbacks and
complement the current technologies.
In that context, magnetic trapping may represent an
interesting alternative. For many years, magnetic beads
(MBs) have been widely used in chemical and biological
engineering. For example, selective separation and collection
of target analytes using MBs is regularly used in immu-
noassay protocols [21, 22]. Also, the good compatibility of
MBs with microfluidic platforms has been demonstrated
through the fabrication of a microreactor allowing efficient
and very fast tryptic digestion of protein [23].
An early report on the online application of MBs in CE
has been published by Rashkovetsky et al. in 1997 [24]. They
reported the magnetic trapping of functionalized MBs
(2.8 mm) into a fused-silica capillary for enzymatic reaction
and immunocapture. In this last case, sheep Ig covalently
coated MBs have been used to capture a mouse mAb. After
capture, the mouse antibody was released, preconcentrated
by ITP, and quantified by UV detection. Although this frit-
less approach for online IA-CE was promising, only feasi-
bility was demonstrated. Since this pioneering work, other
applications of MBs in CE were presented for electrochro-
matography [25, 26], protein capture [27, 28], and affinity
preconcentration [29]. However, to the best of our knowl-
edge, no research about MBs-based IA-CE was reported.
In the present work, protein A-coated MBs were trap-
ped into a neutrally coated capillary as a support for anti-
body. After bounding the antibody of interest on the MBs,
the corresponding antigen was immunocaptured and pre-
concentrated online. Then, the immunological complex
was dissociated under acidic conditions and the respective
antibody and antigen were stacked by transient ITP (t-ITP)
and further separated by CZE. Taking b-lactoglobulin
(b-LG) as a model analyte, optimized conditions for MBs
trapping, immunocapture, t-ITP, CZE separation, non-
specific adsorption, and reproducibility were investigated
in detail. b-LG is the most abundant whey protein in milk,
but it is also one of the major allergens in bovine milk [30].
Its detection and quantification is thus important in the
control of food quality. For these reasons, reliability and
practicability of the developed IA-CE method were eval-
uated by determining the native b-LG concentration in
different milk samples.
2 Materials and methods
2.1 Chemicals
Protein A-coated superparamagnetic beads of uniform size
(mean diameter 0.3 mm) were purchased from Ademtech
(France). Rabbit antibovine b-LG polyclonal antibody (1 mg/
mL in PBS) was obtained from GeneTex (San Antonio, TX,
USA). b-LG from bovine milk (90%), BSA (98%), and poly-
oxyethylene-sorbitan monolaurate (Tween-20) were pur-
chased from Sigma–Aldrich (Buchs, Switzerland). Hydroxy-
propylcellulose (HPC) was from Acros (Chemie Brunschwig
AG, Basel, Switzerland). Acetic acid (99.5%) was purchased
from Fluka (Buchs, Switzerland) and ammonium acetate
(98%) from Merck (Darmstadt, Germany). All buffer and
sample solutions were prepared with water produced by an
alpha Q-Millipore System (Zug, Switzerland). Commercial
milk samples of different types (pasteurized and skimmed
bovine milk powder (35 g protein/100 g), ultra-high-temper-
ature (UHT)-treated bovine liquid milk and liquid soy milk)
were purchased from a local supermarket.
Throughout the experiments, the following buffers were
used: binding and leading buffer (ammonium acetate
100 mM, pH 8.0); sample buffer (binding buffer with 0.5%
BSA and 0.1% Tween), elution buffer and separation buffer
(10% v/v acetic acid). The suspension of MBs was prepared
daily by sonicating and diluting 20 times the commercial so-
lution with distilled water. Anti-b-LG polyclonal antibody
(100 mg/mL) was also daily prepared by diluting the stock
solution with binding buffer. b-LG (2.5 mg/mL) was pre-
pared in sample buffer, aliquoted, and stored at 2207C. All
the milk samples were obtained after centrifugation and fil-
tration through 20-mm Nalgene filter units (VWR, Dietikon,
Switzerland).
2.2 Apparatus
All experiments were carried out on a PACE MDQ system
(Beckman Coulter, Nyon, Switzerland) equipped with a
photo-DAD, an autosampler, and a power supply able to de-
liver up to 30 kV. Fused-silica capillaries (50 mm id, 375 mm
od, 30 cm effective length, 40 cm total length) were obtained
from BGB Analytik AG (Böckten, Switzerland) and coated
with HPC following the procedure described by Shen et al.
[31] to limit as much as possible the EOF and sample
adsorption. The magnetic field was applied by two round
magnets (Nd-Fe-B, 5 mm diameter, 2 mm thickness, Super-
Magnete, Zürich, Switzerland), which were placed directly
around the capillary at a distance of 11 cm from the inlet. To
arrange the magnets around the capillary, the cooling system
of the apparatus was disabled and the coolant tube removed.
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2.3 Procedure for online immunocapture and
separation
Step 1: MBs trapping; a uniform suspension of MBs was
injected into the capillary for 3 min at 34.5 mbar.
Step 2: Antibody immobilization; anti-b-LG antibodies
(100 mg/mL) were injected for 10 min at 34.5 mbar.
Step 3: Antigen immunocapture; b-LG (standard solutions or
samples) were injected for a given period of time at
34.5 mbar.
Step 4: Washing; the binding buffer was injected at
34.5 mbar for 10 min to remove unbound proteins and
totally fill the capillary. This binding buffer was used as the
leading buffer for ITP stacking.
Step 5: Reverse rinsing; a plug of separation buffer was
injected at 34.5 mbar from the outlet vial.
Step 6: Release and separation of the antigens and anti-
bodies; 15 kV was applied from anode to cathode with elec-
trode compartments filled with separation buffer. As elec-
trophoresis occurs, the pH in the zone of MBs gradually
diminishes till a value where the immunocomplexes are dis-
sociated. The antigen and the antibody are then released
from the MBs, stacked by t-ITP and finally separated by CZE.
Step 7: MBs removal; the trapped MBs are removed at the
end of each analysis by flushing at high pressure
(1379 mbar) with separation buffer. The different steps are
illustrated in Fig. 1.
Figure 1. Schematic presentation of the procedure for online
immunocapture and separation.
2.4 Quantification of -LG
The developed procedure was first tested with standard b-LG
solutions (0.001–2.5 mg/mL). Three repetitions at each con-
centration were performed. A calibration curve was then
constructed by plotting the corrected peak area (A/t) as a
function of the concentration. In order to fit in the linear
range of the calibration curve, milk samples were first dilut-
ed with sample buffer. One-tenth diluted pasteurized skim-
med milk powder (5 mg/mL) and 1/200 diluted UHT liquid
milk were analyzed. 1/10 diluted soy milk was taken as a
control. Again, three repetitions have been performed. The
b-LG concentration was then calculated for each sample by
taking into account the mean value of the repetitions, the
calibration curve and the dilution factor.
3 Results and discussion
3.1 MB trapping and stability in capillary
MBs with different diameters (2.8, 1, and 0.3 mm) were inves-
tigated. While the largest beads exhibit the highest magnetic
susceptibility, the smallest ones present the lowest sedi-
mentation rate. Consequently, MBs presenting a mean diam-
eter of 0.3 mm have been chosen. This kind of beads stays as a
rather uniform suspension for a considerable time, which is
of importance in order to obtain a suitable reproducibility.
Furthermore, the small size of MBs provides a high surface
area to volume ratio, which not only reduces the diffusion
distance for all steps but also increases the density of binding
sites for immobilization of antibody. Moreover, as shown in
Fig. 2, small MBs can be trapped in the capillary by the mag-
netic field by using reduced pressure and easily removed by
applying a high pressure. As the UV absorption of MBs is
proportional to the amount trapped in the capillary, Fig. 2
shows an increase in trapped MBs when injection time
increased. Although more MBs are advantageous for the fol-
lowing immunoaffinity step, it induces a higher resistance to
the flow and thus requires long washing times. In an extreme
case, it can even lead to a blocking of the capillary resulting in
current breakdown. In our experiments, a 3 minMBinjection
time has been chosen because it provides a good compromise
between loading capacity, speed, and current stability.
Figure 2. UV response corresponding to the high-pressure
removal of the magnetically trapped MBs. Conditions: HPC-
coated capillary, total/effective length 40/30 cm650 mm id, UV
absorbance at 200 nm. Injection sequence: protein A-coated MBs
(0.3 mm) injection: 34.5 mbar for (A) 1 min, (B) 3 min, (C) 5 min;
washing with water: 34.5 mbar for (A) 22 min, (B) 22 min, (C)
26 min; MB removal step with water: 1379 mbar for 2 min.
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For its potential use as a support for immunocapture, it
is important to make the trapping of MBs stable. To
achieve this, a required condition is to make the magnetic
forces dominate over the competing forces [24], which is
pressure and electric field in our system. Due to the very
small diameter of the used MBs, their magnetic suscepti-
bility is rather limited. Consequently, to avoid the compet-
ing forces outweighing the magnetic force, the experi-
mental conditions had to be optimized. In our setup, MBs
removal was observed at a pressure of 69 mbar (Fig. 3a).
A 34.5 mbar pressure was thus used for all the injection
and rinsing steps. At the end of each run, a high pressure
of 1379 mbar was performed in order to remove the trap-
ped MBs from the capillary. Then, it was important to
know if the MBs can sustain the electric field without
being removed. To test the stability of the MBs under
electric field, a voltage ranging from 10 to 25 kV was
applied during 20 min after the injection of the MBs in the
capillary. Subsequently, the capillary was rinsed and the
MBs removed by applying a high pressure. As shown in
Fig. 3b, no significant bead losses were observed because
the amount of removed MBs at the end of each analysis was
similar. For all the following electrophoresis experiments, a
voltage of 15 kV was applied.
3.2 Online immunoaffinity and separation
Protein A-coated MBs were used for the immobilization of
anti-b-LG antibody. Specific binding happened at the Fc part
of the antibody, thus controlling its orientation and making
its paratopes fully available to react with its antigen. In a first
step, to assure a maximum loading capacity to the immuno-
sorbent, the antibody injection was optimized to work at
saturation of the MBs. To proceed to this optimization, the
antibody was injected for a given period of time. Then, after
the washing step that permits to remove the unbound anti-
bodies, the bound ones were released and electrophoretically
transported toward the detector by the previously described
procedure. As can be seen in Fig. 4a, the quantity of bound
antibodies increased with the injection time until 5 min and
then remained stable. To provide a maximum loading ca-
pacity to the immunosorbent, 10 min was thus chosen for
the injection of the antibody.
After having loaded the anti-b-LG antibody into the cap-
illary at a saturated level (injection for 10 min), the antigen
was injected for a given period of time. To allow the different
immunoreactions to occur, all the protein samples were dis-
solved in binding buffer (100 mM ammonium acetate,
pH 8.0). After the immunoaffinity step, unbound proteins
were washed by rinsing with binding buffer for another
10 min. Then, separation buffer (10% v/v acetic acid, pH 2.0)
was introduced from the outlet vial to fill a determined por-
tion of the capillary. The further voltage application while the
separation buffer was placed in both electrode compartments
allowed the dissociation of the different immunocomplexes,
the ITP preconcentration and finally the CZE separation of
the antibody and antigen. As shown in Figs. 4b and 5,
results demonstrate the successful capture and separation of
anti-b-LG antibody and b-LG. Thanks to the miniaturized
format of the capillary, all the immunoaffinity reactions
happened rapidly at room temperature and no incubation
time was needed.
Another interesting feature of the developed system, in
addition to allow an online immunoselection, is its ability to
preconcentrate a protein of interest. As can be seen from
Figs. 4b and 5, when the sample presents a low concentra-
Figure 3. Stability of trapped MBs under applied pressure (a) and voltage (b). Conditions: HPC-coated capillary, total/effective length 40/
30 cm650 mm id, UVabsorbance at 200 nm. Injection sequence: protein A-coatedMBs (0.3 mm) injection: 34.5 mbar for 3 min; (a) washing with
bindingbuffer: 34.5 mbarfor10 min,50 mbarfor5 min,69 mbarfor3 minand1379 mbarfor2 min; (b) removalof trappedMBsbyhigh-pressure
(1379 mbar) application after applying different voltages (10, 15, 20, 25 kV) for 20 min.
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Figure 4. (a) Plot of peak height of antibody versus injection time.
Anti-b-LG antibody, 100 mg/mL. (b) Plot of peak height of b-LG ver-
sus injection time. b-LG, 1 mg/mL; antibody injection for 10 min.
Figure 5. Sample preconcentration by increasing the percolating
time of the sample. Peak 1, b-LG; Peak 2, anti-b-LG antibody.
Conditions: HPC-coated capillary, total/effective length 40/
30 cm650 mm id, UV absorbance at 200 nm. Injection sequence:
protein A-coated MBs (0.3 mm) injection: 34.5 mbar for 3 min;
anti-b-LG antibody (100 mg/mL in binding buffer) injection:
34.5 mbar for 10 min; b-LG solution (1 mg/mL in sample buffer)
injection: 34.5 mbar for (A) 1 min, (B) 5 min, (C) 10 min, (D)
20 min, (E) 30 min; washing with binding buffer: 34.5 mbar for
10 min; reverse injection of separation buffer: 34.5 mbar for
5.5 min; elution and separation: applied voltage, 15 kV; MB
removal step with separation buffer: 1379 mbar for 2 min.
tion, the injection time can be varied in order to provide a
suitable sensitivity for further analysis and/or quantification.
As an illustration, it is shown for b-LG that an injection time
of 1 min is not sufficient for detecting this protein if its con-
centration in the sample is 1 mg/mL. However, the sensitivity
can be linearly improved by increasing the sample injection
time to 20 min. Thus, depending on the sample to be stud-
ied, as different sensitivity levels could be achieved, the
experimental conditions can be tuned to fulfill the require-
ments.
3.3 Stacking by ITP
With the present experimental conditions, the binding
(ammonium acetate) and the separation (acetic acid) buffers
have been chosen as they constitute a well-known buffer
system for conducting cationic ITP at acidic pH. As it is
demonstrated in Fig. 6, adjusting the reverse rinsing step
duration permitted to set the magnitude of the t-ITP pre-
concentration. As a longer reverse rinsing duration reduced
the ammonium acetate zone length, the amount of leading
ions and thus the stacking effect were concomitantly
decreased. In addition to t-ITP, as the binding and the
separation buffer present very different pH values, pre-
concentration by dynamic pH junction should also occur.
While a strong stacking brings a high efficiency and sensi-
tivity, meanwhile, it leads to some drawbacks. First, as the
stacking is increased, the resolution is decreased because the
available time for CZE separation is reduced. Second, in
extreme stacking conditions, the local protein or antibody
concentration can reach the respective limit of solubility and
consequently induce precipitation. Ultimately, this can pro-
voke the blocking of the capillary. A good compromise had
thus to be found. From Fig. 6, it could be concluded that a
1 min reverse rinsing time constituted the best condition,
however, the current was not very stable under these condi-
tions. For this reason, a 2 min reverse rinsing time has been
chosen for the next experiments.
Figure 6. Variation of the t-ITP magnitude by varying the reverse
rinsing time of separation buffer. Peak 1, b-LG; peak 2, anti-b-LG
antibody. Conditions: b-LG solution (1 mg/mL in sample buffer)
injection: 34.5 mbar for 2 min; other conditions are the same as in
Fig. 5.
3.4 Nonspecific adsorption
Another important problem in any immunoaffinity meth-
odology stems from the nonspecific adsorption of proteins
on the immunosorbent phase. It usually decreases the
selectivity of a method, especially when complex real sam-
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ples have to be analyzed. From this point of view, it was very
important to minimize as much as possible these interac-
tions. However, Van der Waals, hydrophobic and electrostatic
interactions always exist between proteins and different sur-
faces, coating a fused-silica capillary with a polymer by cova-
lent bonding or physical adsorption is usually the most
effective way to diminish these interactions in CE. Different
additives could also be used to avoid the nonspecific reten-
tion of compounds. Both approaches were applied in our
method. HPC-coated capillaries as well as 0.1% Tween in
sample solutions have been used. Also, to mimic real condi-
tions, all sample solutions used in the following experiments
contained a 0.5 mg/mL concentration of BSA. It is proven in
Fig. 7 that the chosen experimental conditions keep the
nonspecific adsorption contribution at an acceptable level.
Figure 7. Nonspecific adsorption assessment. Conditions: (A) b-
LG solution (2.5 mg/mL in sample buffer) injection: 34.5 mbar for
2 min. (B) Control sample (BSA 0.5 mg/mL in sample buffer)
injection: 34.5 mbar 2 min; reverse rinsing of separation buffer:
34.5 mbar for 2 min; other conditions are the same as in Fig. 5.
3.5 Quantification of -LG in milk
To further assess the native b-LG concentrations in different
milk samples, a calibration curve has been constructed. The
results obtained are shown in Fig. 8. A linear evolution of the
corrected area was observed for b-LG concentrations ranging
from1 to17.5 mg/mL (R2 = 0.98). Atrend toward saturationwas
observed for concentrations above 17.5 mg/mL. For each point
of the calibration curve, an RSD between 2.6 and 6.9% has been
calculated. This rather good repeatability was likely due to the
renewal of the MBs before each run. Also, before each MB
injection, the suspensionwashomogenized by gentlemixing to
minimize the effects of sedimentation. Under the used experi-
mental conditions, anLOQof1 mg/mLhasbeendetermined for
b-LG. This corresponds approximately to a protein concentra-
tion of 55 nM. However, as demonstrated in Fig. 5, an LOD in
the very low nanomolar range can be expected by increasing the
sample injection time.
Figure 8. Calibration curve for b-LG quantification. Conditions:
except the b-LG concentration, conditions are the same as in
Fig. 7.
The developed procedure was then applied to quantify
the concentration of native b-LG in two different commer-
cially available milks. The corresponding electropherograms
are shown in Fig. 9. As samples, two bovine milks with dif-
ferent processing treatments have been analyzed. Soy milk,
as a control sample, has also been considered in the study.
Taking into account the calibration curve, it has been deter-
mined that the skimmed milk powder presents a native b-LG
concentration of 12.77 6 0.58 mg/g and the UHT milk a
concentration equal to 0.47 6 0.01 mg/mL. As compared to
other references that mention the concentration of b-LG in
raw milk [32, 33], the concentrations that we have deter-
mined are lower. Now, it is well known that b-LG is highly
sensitive to temperature [34]. Indeed, in the latter work, it
has for example been shown that the native concentration of
b-LG decreases from 3.5 to less than 0.5 mg/mL after 90 s at
957C. Thus, if we consider that the two bovine milks, which
have been analyzed had undergone pasteurization or UHT
process (1357C for a short time), and that the used antibodies
may recognize conformational but not linear epitopes, the
obtained results appear fully reasonable. For soy milk, as
expected, no b-LG was detected. As this sample presents a
high total protein concentration, this confirms that non-
specific adsorption is not a significant problem with the
developed protocol. All these results clearly demonstrate that
this MBs-based IA-CE methodology is effective and reliable
for real biological sample analyses. As compared to other
immunosorbent previously reported in the literature, the
main advantage of the use of MBs in IA-CE is undoubtedly
the possibility to renew the stationary phase after each anal-
ysis. Indeed, as it has been demonstrated, the MBs can be
easily washed out from the capillary by simply applying a
high-pressure rinse. Under these conditions, if the non-
specific adsorption on the capillary walls is significantly
avoided, different samples can be analyzed successively in
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Figure 9. Electropherograms demonstrating the detection of b-
LG from milk samples after online immunocapture. Conditions:
(A) pasteurized skimmed milk sample (5 mg/mL, 1/10 diluted); (B)
UHT milk sample (1/200 diluted); (C) soy milk (1/10 diluted, con-
trol). Reverse rinsing time, 2 min; other conditions are the same
as in Fig. 6.
the same capillary without any memory effects. Also, if the
concentrations of different antigens in a given sample have
to be determined by IA-CE and if the respective functional-
ized MBs are available, one can envisage proceeding succes-
sively with the different analyses in one single capillary. In
that context, a higher throughput can be reached with the
MBs-based IA-CE system. From another point of view, it is
well known that it can be difficult in some cases to recover
bound analytes from their capture antibody. If MBs are used
for the immunoaffinity step, harsh elution conditions, which
can denature the capture antibodies, can be used given that a
new set of antibody will be used for the following experi-
ment. A higher recovery rate and a higher sensitivity could
then be expected.
4 Concluding remarks
Protein A-coated MBs (0.3 mm) have been trapped in a neu-
trally coated capillary for conducting immunocapture of
b-LG. Thanks to the affinity of protein A toward different
mammalian Igs, a polyclonal anti-b-LG antibody, raised
in rabbit has been immobilized on the surface of the
MBs. As protein A binds the Fc part of the antibodies,
the reactivity of anti-b-LG antibody was fully preserved in
spite of its immobilization on the immunosorbent MBs.
In addition, the miniaturized format of the experimental
setup provided a high density of binding sites and rapid
mass transfers that allowed capturing b-LG online with-
out the need of any incubation time. After immuno-
capture at pH 8, the partial-filling of the capillary with
different buffers and the subsequent application of a
voltage led successively to the dissociation of the differ-
ent immunocomplexes, the t-ITP preconcentration of the
antibody and antigen and their final separation by CZE.
The developed method was applied to the quantification
of b-LG in both standard solutions and commercial milk
samples. Excellent reproducibility (RSD = 2.6–6.9%) and
trustworthy results confirmed the effectiveness and relia-
bility of the method. As compared to other online IA-CE
techniques, a distinct advantage of the described
approach is the simple and automated preparation of an
immunoaffinity support that can be renewed after each
analysis.
An LOQ of 55 nM has been achieved in this work but the
LOD can further be lowered through large sample volume
percolation. Then, if the sensitivity still needs to be
enhanced, the use of fluorescence detection could represent
a very interesting alternative however a labeled secondary
antibody would have to be used if native fluorescence is not
employed. In that case, the sensitivity of the method would
certainly be improved but this would make the immu-
noassay more complex and the detection of the native anti-
gen impossible.
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